SCHEMBL1463154

SCHEMBL1463154

CC(C)(C)OC(=O)N1CCC(c2nc(Cl)c(F)cc2[N+](=O)[O-])CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.43
KDM4E B2RXH2 2/20 0.43
THRB P10828 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
GPR119 Q8TDV5 4/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 1/20 0.41
DPP4 P27487 1/20 0.41
CNR1 P21554 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
GPR35 Q9HC97 1/20 0.41
GPR55 Q9Y2T6 1/20 0.41
GPR174 Q9BXC1 1/20 0.41
TRPV3 Q8NET8 1/20 0.41
MEN1 O00255 2/20 0.40
HPGD P15428 2/20 0.40
KMT2A Q03164 2/20 0.40
HSD17B10 Q99714 2/20 0.40
USP2 O75604 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1463152 0.90 MAPT (0.45) MAPTKDM4ETHRBSMN1; SMN2GPR119
SCHEMBL1420920 0.88 GPR119 (0.44) MAPTKDM4ETHRBGPR119ALDH1A1
SCHEMBL1420738 0.84 GPR174 (0.37) MAPTSMN1; SMN2ALDH1A1LMNAGPR174
SCHEMBL1462885 0.83 MAPT (0.46) MAPTKDM4ETHRBSMN1; SMN2GPR119
SCHEMBL1462908 0.83 GPR119 (0.44) MAPTKDM4ETHRBSMN1; SMN2GPR119
SCHEMBL1082361 0.77 GPR119 (0.46) MAPTKDM4ETHRBSMN1; SMN2GPR119
SCHEMBL1463303 0.77 MAPT (0.45) MAPTKDM4ETHRBGPR119ALDH1A1
SCHEMBL28651590 0.77 NAMPT (0.47) MAPTKDM4ETHRBSMN1; SMN2GPR119
SCHEMBL24582171 0.76 MAPT (0.46) MAPTKDM4ETHRBSMN1; SMN2GPR119
SCHEMBL16249707 0.75 GPR119 (0.46) MAPTSMN1; SMN2GPR119ALDH1A1GPR174

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10034476-B2 Insecticidal phenyl-or pyridyl-piperdine compounds SYNGENTA PARTICIPATIONS AG (CH) 2018-07-31 US disclosed
US-20170347650-A1 INSECTICIDAL PHENYL-OR PYRIDYL-PIPERDINE COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2017-12-07 US disclosed
US-9808006-B2 Insecticidal phenyl-or pyridyl-piperdine compounds SYNGENTA PARTICIPATIONS AG (CH) 2017-11-07 US disclosed
US-20130317062-A1 INSECTICIDAL PHENYL-OR PYRIDYL-PIPERDINE COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2013-11-28 US disclosed
US-8193362-B2 Insecticidal compounds SYNGENTA CROP PROTECTION LLC (US) 2012-06-05 US disclosed
WO-2012037282-A3 CATALYSTS AND METHODS FOR POLYMER SYNTHESIS NOVOMER, INC. (US) 2012-05-10 WO disclosed
EP-2297136-B1 INSECTICIDAL PYRIDYLPIPERIDINE COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2011-12-28 EP disclosed
EP-2324010-B1 INSECTICIDAL PHENYL- OR PYRIDYL-PIPERIDINE COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2011-11-30 EP disclosed
US-20110071191-A1 INSECTICIDAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10034476-B2 Insecticidal phenyl-or pyridyl-piperdine compounds ACHE, CHRM1, CHRM2 MAPT 3218/4885KDM4E 1032/4885THRB 3436/4885
US-20130317062-A1 INSECTICIDAL PHENYL-OR PYRIDYL-PIPERDINE COMPOUNDS ACHE, CHRM1, CHRM2 MAPT 3218/4885KDM4E 1032/4885THRB 3436/4885
US-20110071191-A1 INSECTICIDAL COMPOUNDS CBR3, CBR1, ACHE MAPT 4567/4885KDM4E 1894/4885THRB 3113/4885
US-20170347650-A1 INSECTICIDAL PHENYL-OR PYRIDYL-PIPERDINE COMPOUNDS ACHE, CHRM1, CHRM2 MAPT 3218/4885KDM4E 1032/4885THRB 3436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.